Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SYK | P43405 | 4/20 | 0.63 |
| ▸ | BTK | Q06187 | 3/20 | 0.63 |
| ▸ | LYN | P07948 | 2/20 | 0.63 |
| ▸ | TXK | P42681 | 1/20 | 0.63 |
| ▸ | CDK1 | P06493 | 6/20 | 0.55 |
| ▸ | CDK2 | P24941 | 6/20 | 0.55 |
| ▸ | CCNT1 | O60563 | 5/20 | 0.55 |
| ▸ | CCNB1 | P14635 | 5/20 | 0.55 |
| ▸ | CCNA2 | P20248 | 5/20 | 0.55 |
| ▸ | CDK9 | P50750 | 5/20 | 0.55 |
| ▸ | CDK7 | P50613 | 4/20 | 0.55 |
| ▸ | CCNH | P51946 | 4/20 | 0.55 |
| ▸ | CCNA1 | P78396 | 3/20 | 0.55 |
| ▸ | JAK3 | P52333 | 8/20 | 0.55 |
| ▸ | JAK1 | P23458 | 7/20 | 0.55 |
| ▸ | EPHB4 | P54760 | 2/20 | 0.52 |
| ▸ | EGFR | P00533 | 2/20 | 0.51 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.50 |
| ▸ | AURKA | O14965 | 2/20 | 0.50 |
| ▸ | DCLK1 | O15075 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3620405 | 0.86 | CDK1 (0.55) | SYKBTKLYNTXKCDK1 | |
| SCHEMBL3613897 | 0.83 | CDK1 (0.57) | SYKBTKLYNTXKCDK1 | |
| SCHEMBL3620313 | 0.82 | CDK1 (0.55) | SYKBTKLYNTXKCDK1 | |
| SCHEMBL3622441 | 0.80 | IKBKB (0.59) | SYKBTKLYNTXKCDK1 | |
| SCHEMBL3622052 | 0.79 | CDK2 (0.54) | SYKBTKLYNTXKCDK1 | |
| SCHEMBL3621559 | 0.79 | CDK2 (0.54) | SYKBTKLYNTXKCDK1 | |
| SCHEMBL3618216 | 0.79 | CDK2 (0.55) | SYKBTKLYNCDK1CDK2 | |
| SCHEMBL5813797 | 0.78 | EPHB4 (0.62) | SYKBTKLYNTXKCDK9 | |
| SCHEMBL3607870 | 0.78 | JAK1 (0.50) | SYKBTKCDK1CDK2CCNT1 | |
| SCHEMBL3619732 | 0.78 | CDK2 (0.53) | SYKBTKLYNCDK1CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100093776-A1 | Organic Compounds and Their Uses | NOVARTIS AG | 2010-04-15 | — | — | US | disclosed |
| US-20100093776-A1 | Organic Compounds and Their Uses | NOVARTIS AG | 2010-04-15 | — | — | US | disclosed |
| US-20100093776-A1 | Organic Compounds and Their Uses | NOVARTIS AG | 2010-04-15 | — | — | US | disclosed |
| WO-2008079918-A1 | INDOL-4-YL-PYRIMIDINYL-2-YL-AMINE DERIVATIVES AND USE THEREOF AS CYCLIN DEPENDANT KINASE INHIBITORS | NOVARTIS AG (CH) | 2008-07-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100093776-A1 | Organic Compounds and Their Uses | OAT, OTC, AOX1 | SYK 2976/4885BTK 3479/4885LYN 2590/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.